Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban-Reference-Cited by-同舟云学术

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban

Published:2016-02-17 Issue:13 Volume:102 Page:1036-1043
ISSN:1355-6037
Container-title:Heart
language:en
Short-container-title:Heart

Author:

Breithardt Günter,Baumgartner Helmut,Berkowitz Scott D,Hellkamp Anne S,Piccini Jonathan P,Lokhnygina Yuliya,Halperin Jonathan L,Singer Daniel E,Hankey Graeme J,Hacke Werner,Becker Richard C,Nessel Christopher C,Mahaffey Kenneth W,Califf Robert M,Fox Keith A A,Patel Manesh R

Publisher

BMJ

Subject

Cardiology and Cardiovascular Medicine

Reference46 articles.

1. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study;ROCKET AF Study Investigators;Am Heart J,2010

2. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011

3. Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial;Breithardt;Eur Heart J,2014

4. Atrial fibrillation, valvular heart disease, and use of target-specific oral anticoagulants for stroke prevention;Hohnloser;Eur Heart J,2014

5. Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial;Avezum;Circulation,2015

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aortic Stenosis and Outcomes in Patients With Atrial Fibrillation: A Nationwide Cohort Study;Journal of the American Heart Association;2023-05-02

2. Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease;Annals of Internal Medicine;2022-11

3. Comparison of Direct Oral Anticoagulants and Warfarin in the Prevention of Stroke in Patients With Valvular Heart Disease: A Meta-Analysis;Cureus;2022-09-04

4. Comparison of the Efficacy and Safety of Apixaban and Warfarin in the Prevention of Stroke in Patients With Non-valvular Atrial Fibrillation: A Meta-Analysis;Cureus;2022-08-09

5. Mitral Regurgitation and Body Mass Index Increase the Predictability of Perioperative Bleeding in Anticoagulated Patients With Nonvalvular Atrial Fibrillation;Frontiers in Cardiovascular Medicine;2022-03-28